Michael Gelband’s BioLife Solutions BLFS Stock Holding History

Michael Gelband’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.15M	Buy	+76,120	New	+$1.78M	0.01%	787
2025 Q4	–	Sell	-36,055	Closed	-$920K	–	1562
2025 Q3	$920K	Buy	+36,055	New	+$855K	0.01%	995
2025 Q1	–	Sell	-26,662	Closed	-$692K	–	1485
2024 Q4	$692K	Sell	26,662 -3,957	-13%	-$98.5K	﹤0.01%	1060
2024 Q3	$767K	Buy	+30,619	New	+$723K	﹤0.01%	1053
2022 Q2	–	Sell	-10,538	Closed	-$240K	–	1964
2022 Q1	$240K	Buy	+10,538	New	+$277K	﹤0.01%	1843
2021 Q2	–	Sell	-21,444	Closed	-$772K	–	2356
2021 Q1	$772K	Buy	+21,444	New	+$848K	0.01%	1073
2019 Q2	–	Sell	-24,987	Closed	-$447K	–	1106
2019 Q1	$447K	Buy	+24,987	New	+$397K	0.03%	363

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Michael Gelband's BLFS Position: Q2 2026 in Review

Michael Gelband opened a new position in BioLife Solutions (BLFS) in Q2 2026: 76,120 shares worth $2.15M. The stake represents 0.01% of the portfolio and ranks #787 among its holdings. This is a return to the name: Michael Gelband previously reported a position in BLFS as recently as Q3 2025.

Michael Gelband first reported a position in BLFS in Q1 2019 and has held it in 7 quarters since. 215 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Michael Gelband held 76,120 shares of BioLife Solutions worth $2.15M as of Q2 2026.
BioLife Solutions was a new Michael Gelband position in Q2 2026.
BioLife Solutions made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #787 holding.
Michael Gelband first reported a position in BioLife Solutions in Q1 2019 and has held it in 7 quarters since.
215 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.